 "Stock recommendation by Prabhudas Lilladher: Buy Hindalco, Aurobindo Pharma")
BUY HINDALCO | CMP: Rs 179.80 | Target: Rs 215-225 | Stop Loss: Rs 160
The stock has formed a base near 153 levels and has picked up momentum with stability seen at current 170 levels. The RSI indicator has recently indicated a decent rise to imply strength and we anticipate further upward movement in the coming days. We suggest to buy and accumulate this stock for an upside target of Rs 215-225 levels, keeping the stop loss of Rs 160.
BUY AURO PHARMA | CMP: Rs 806.25 | Target: Rs 920-940 | Stop Loss: Rs 750
The stock has witnessed some correction in recent times and has currently indicated signs of bottoming out and reversing the trend with improvement in the bias. The RSI also has shown improvement with a trend reversal and we anticipate further upward movement from here on. We suggest to buy and accumulate this stock for an upside target of Rs 920-940, keeping the stop loss of Rs 750.
===============================
Disclaimer: The author is an analyst with Prabhudas Lilladher. She may have positions in one or more stocks mentioned above. Views are personal.
===============================
Disclaimer: The author is an analyst with Prabhudas Lilladher. She may have positions in one or more stocks mentioned above. Views are personal.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%